MiR-497∼195 cluster regulates angiogenesis during coupling with osteogenesis by maintaining endothelial Notch and HIF-1α activity
A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31 hi Emcn hi ), is identified as coupling angiogenesis and osteogenesis. The abundance of type CD31 hi Emcn hi vessels decrease during ageing. Here we show that expression of the miR-497∼195 cluster is high in CD31 hi Emcn...
Saved in:
Published in | Nature communications Vol. 8; no. 1; pp. 16003 - 11 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
07.07.2017
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
ISSN | 2041-1723 2041-1723 |
DOI | 10.1038/ncomms16003 |
Cover
Abstract | A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31
hi
Emcn
hi
), is identified as coupling angiogenesis and osteogenesis. The abundance of type CD31
hi
Emcn
hi
vessels decrease during ageing. Here we show that expression of the miR-497∼195 cluster is high in CD31
hi
Emcn
hi
endothelium but gradually decreases during ageing. Mice with depletion of miR-497∼195 in endothelial cells show fewer CD31
hi
Emcn
hi
vessels and lower bone mass. Conversely, transgenic overexpression of miR-497∼195 in murine endothelium alleviates age-related reduction of type CD31
hi
Emcn
hi
vessels and bone loss. miR-497∼195 cluster maintains the endothelial Notch activity and HIF-1α stability via targeting F-box and WD-40 domain protein (Fbxw7) and Prolyl 4-hydroxylase possessing a transmembrane domain (P4HTM) respectively. Notably, endothelialium-specific activation of miR-195 by intravenous injection of aptamer-agomiR-195 stimulates CD31
hi
Emcn
hi
vessel and bone formation in aged mice. Together, our study indicates that miR-497∼195 regulates angiogenesis coupled with osteogenesis and may represent a potential therapeutic target for age-related osteoporosis.
H-type endothelium, defined by the high expression of CD31 and endomucin, is found in the bone where it promotes angiogenesis and osteogensis. Here Yang
et al
. show that the miR-497∼195 cluster regulates the generation and maintenance of the H-type endothelium by controlling the levels of Notch regulator Fbxw7 and the HIF regulator P4HTM. |
---|---|
AbstractList | A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31hiEmcnhi), is identified as coupling angiogenesis and osteogenesis. The abundance of type CD31hiEmcnhi vessels decrease during ageing. Here we show that expression of the miR-497∼195 cluster is high in CD31hiEmcnhi endothelium but gradually decreases during ageing. Mice with depletion of miR-497∼195 in endothelial cells show fewer CD31hiEmcnhi vessels and lower bone mass. Conversely, transgenic overexpression of miR-497∼195 in murine endothelium alleviates age-related reduction of type CD31hiEmcnhi vessels and bone loss. miR-497∼195 cluster maintains the endothelial Notch activity and HIF-1α stability via targeting F-box and WD-40 domain protein (Fbxw7) and Prolyl 4-hydroxylase possessing a transmembrane domain (P4HTM) respectively. Notably, endothelialium-specific activation of miR-195 by intravenous injection of aptamer-agomiR-195 stimulates CD31hiEmcnhi vessel and bone formation in aged mice. Together, our study indicates that miR-497∼195 regulates angiogenesis coupled with osteogenesis and may represent a potential therapeutic target for age-related osteoporosis. H-type endothelium, defined by the high expression of CD31 and endomucin, is found in the bone where it promotes angiogenesis and osteogensis. Here Yang et al. show that the miR-497∼195 cluster regulates the generation and maintenance of the H-type endothelium by controlling the levels of Notch regulator Fbxw7 and the HIF regulator P4HTM. A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31hiEmcnhi), is identified as coupling angiogenesis and osteogenesis. The abundance of type CD31hiEmcnhi vessels decrease during ageing. Here we show that expression of the miR-497∼195 cluster is high in CD31hiEmcnhi endothelium but gradually decreases during ageing. Mice with depletion of miR-497∼195 in endothelial cells show fewer CD31hiEmcnhi vessels and lower bone mass. Conversely, transgenic overexpression of miR-497∼195 in murine endothelium alleviates age-related reduction of type CD31hiEmcnhi vessels and bone loss. miR-497∼195 cluster maintains the endothelial Notch activity and HIF-1α stability via targeting F-box and WD-40 domain protein (Fbxw7) and Prolyl 4-hydroxylase possessing a transmembrane domain (P4HTM) respectively. Notably, endothelialium-specific activation of miR-195 by intravenous injection of aptamer-agomiR-195 stimulates CD31hiEmcnhi vessel and bone formation in aged mice. Together, our study indicates that miR-497∼195 regulates angiogenesis coupled with osteogenesis and may represent a potential therapeutic target for age-related osteoporosis.A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31hiEmcnhi), is identified as coupling angiogenesis and osteogenesis. The abundance of type CD31hiEmcnhi vessels decrease during ageing. Here we show that expression of the miR-497∼195 cluster is high in CD31hiEmcnhi endothelium but gradually decreases during ageing. Mice with depletion of miR-497∼195 in endothelial cells show fewer CD31hiEmcnhi vessels and lower bone mass. Conversely, transgenic overexpression of miR-497∼195 in murine endothelium alleviates age-related reduction of type CD31hiEmcnhi vessels and bone loss. miR-497∼195 cluster maintains the endothelial Notch activity and HIF-1α stability via targeting F-box and WD-40 domain protein (Fbxw7) and Prolyl 4-hydroxylase possessing a transmembrane domain (P4HTM) respectively. Notably, endothelialium-specific activation of miR-195 by intravenous injection of aptamer-agomiR-195 stimulates CD31hiEmcnhi vessel and bone formation in aged mice. Together, our study indicates that miR-497∼195 regulates angiogenesis coupled with osteogenesis and may represent a potential therapeutic target for age-related osteoporosis. A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31hiEmcnhi), is identified as coupling angiogenesis and osteogenesis. The abundance of type CD31hiEmcnhi vessels decrease during ageing. Here we show that expression of the miR-497∼195 cluster is high in CD31hiEmcnhi endothelium but gradually decreases during ageing. Mice with depletion of miR-497∼195 in endothelial cells show fewer CD31hiEmcnhi vessels and lower bone mass. Conversely, transgenic overexpression of miR-497∼195 in murine endothelium alleviates age-related reduction of type CD31hiEmcnhi vessels and bone loss. miR-497∼195 cluster maintains the endothelial Notch activity and HIF-1α stability via targeting F-box and WD-40 domain protein (Fbxw7) and Prolyl 4-hydroxylase possessing a transmembrane domain (P4HTM) respectively. Notably, endothelialium-specific activation of miR-195 by intravenous injection of aptamer-agomiR-195 stimulates CD31hiEmcnhi vessel and bone formation in aged mice. Together, our study indicates that miR-497∼195 regulates angiogenesis coupled with osteogenesis and may represent a potential therapeutic target for age-related osteoporosis.H-type endothelium, defined by the high expression of CD31 and endomucin, is found in the bone where it promotes angiogenesis and osteogensis. Here Yanget al. show that the miR-497∼195 cluster regulates the generation and maintenance of the H-type endothelium by controlling the levels of Notch regulator Fbxw7 and the HIF regulator P4HTM. A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31 hi Emcn hi ), is identified as coupling angiogenesis and osteogenesis. The abundance of type CD31 hi Emcn hi vessels decrease during ageing. Here we show that expression of the miR-497∼195 cluster is high in CD31 hi Emcn hi endothelium but gradually decreases during ageing. Mice with depletion of miR-497∼195 in endothelial cells show fewer CD31 hi Emcn hi vessels and lower bone mass. Conversely, transgenic overexpression of miR-497∼195 in murine endothelium alleviates age-related reduction of type CD31 hi Emcn hi vessels and bone loss. miR-497∼195 cluster maintains the endothelial Notch activity and HIF-1α stability via targeting F-box and WD-40 domain protein (Fbxw7) and Prolyl 4-hydroxylase possessing a transmembrane domain (P4HTM) respectively. Notably, endothelialium-specific activation of miR-195 by intravenous injection of aptamer-agomiR-195 stimulates CD31 hi Emcn hi vessel and bone formation in aged mice. Together, our study indicates that miR-497∼195 regulates angiogenesis coupled with osteogenesis and may represent a potential therapeutic target for age-related osteoporosis. H-type endothelium, defined by the high expression of CD31 and endomucin, is found in the bone where it promotes angiogenesis and osteogensis. Here Yang et al . show that the miR-497∼195 cluster regulates the generation and maintenance of the H-type endothelium by controlling the levels of Notch regulator Fbxw7 and the HIF regulator P4HTM. Abstract A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31hiEmcnhi), is identified as coupling angiogenesis and osteogenesis. The abundance of type CD31hiEmcnhi vessels decrease during ageing. Here we show that expression of the miR-497∼195 cluster is high in CD31hiEmcnhi endothelium but gradually decreases during ageing. Mice with depletion of miR-497∼195 in endothelial cells show fewer CD31hiEmcnhi vessels and lower bone mass. Conversely, transgenic overexpression of miR-497∼195 in murine endothelium alleviates age-related reduction of type CD31hiEmcnhi vessels and bone loss. miR-497∼195 cluster maintains the endothelial Notch activity and HIF-1α stability via targeting F-box and WD-40 domain protein (Fbxw7) and Prolyl 4-hydroxylase possessing a transmembrane domain (P4HTM) respectively. Notably, endothelialium-specific activation of miR-195 by intravenous injection of aptamer-agomiR-195 stimulates CD31hiEmcnhi vessel and bone formation in aged mice. Together, our study indicates that miR-497∼195 regulates angiogenesis coupled with osteogenesis and may represent a potential therapeutic target for age-related osteoporosis. A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31 Emcn ), is identified as coupling angiogenesis and osteogenesis. The abundance of type CD31 Emcn vessels decrease during ageing. Here we show that expression of the miR-497∼195 cluster is high in CD31 Emcn endothelium but gradually decreases during ageing. Mice with depletion of miR-497∼195 in endothelial cells show fewer CD31 Emcn vessels and lower bone mass. Conversely, transgenic overexpression of miR-497∼195 in murine endothelium alleviates age-related reduction of type CD31 Emcn vessels and bone loss. miR-497∼195 cluster maintains the endothelial Notch activity and HIF-1α stability via targeting F-box and WD-40 domain protein (Fbxw7) and Prolyl 4-hydroxylase possessing a transmembrane domain (P4HTM) respectively. Notably, endothelialium-specific activation of miR-195 by intravenous injection of aptamer-agomiR-195 stimulates CD31 Emcn vessel and bone formation in aged mice. Together, our study indicates that miR-497∼195 regulates angiogenesis coupled with osteogenesis and may represent a potential therapeutic target for age-related osteoporosis. A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31 hi Emcn hi ), is identified as coupling angiogenesis and osteogenesis. The abundance of type CD31 hi Emcn hi vessels decrease during ageing. Here we show that expression of the miR-497∼195 cluster is high in CD31 hi Emcn hi endothelium but gradually decreases during ageing. Mice with depletion of miR-497∼195 in endothelial cells show fewer CD31 hi Emcn hi vessels and lower bone mass. Conversely, transgenic overexpression of miR-497∼195 in murine endothelium alleviates age-related reduction of type CD31 hi Emcn hi vessels and bone loss. miR-497∼195 cluster maintains the endothelial Notch activity and HIF-1α stability via targeting F-box and WD-40 domain protein (Fbxw7) and Prolyl 4-hydroxylase possessing a transmembrane domain (P4HTM) respectively. Notably, endothelialium-specific activation of miR-195 by intravenous injection of aptamer-agomiR-195 stimulates CD31 hi Emcn hi vessel and bone formation in aged mice. Together, our study indicates that miR-497∼195 regulates angiogenesis coupled with osteogenesis and may represent a potential therapeutic target for age-related osteoporosis. |
ArticleNumber | 16003 |
Author | Jiang, Tie-Jian Su, Tian Wan, Mei Yang, Mi Tu, Man-Li Luo, Xiang-Hang Li, Chang-Jun Xiao, Ye He, Hong-Bo Liu, Qing Cao, Xu Lu, Qiong Lei, Min-Xiang Sun, Xi Guo, Qi Peng, Hui |
Author_xml | – sequence: 1 givenname: Mi surname: Yang fullname: Yang, Mi organization: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine – sequence: 2 givenname: Chang-Jun surname: Li fullname: Li, Chang-Jun organization: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine – sequence: 3 givenname: Xi surname: Sun fullname: Sun, Xi organization: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Department of Endocrinology, The Second Xiangya Hospital of Central South University – sequence: 4 givenname: Qi surname: Guo fullname: Guo, Qi organization: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Key Laboratory of Organ Injury, Aging and Regenerative Medicine of Hunan Province – sequence: 5 givenname: Ye surname: Xiao fullname: Xiao, Ye organization: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University – sequence: 6 givenname: Tian surname: Su fullname: Su, Tian organization: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University – sequence: 7 givenname: Man-Li surname: Tu fullname: Tu, Man-Li organization: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine – sequence: 8 givenname: Hui surname: Peng fullname: Peng, Hui organization: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Department of Endocrinology, The Second Xiangya Hospital of Central South University – sequence: 9 givenname: Qiong surname: Lu fullname: Lu, Qiong organization: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University – sequence: 10 givenname: Qing surname: Liu fullname: Liu, Qing organization: Department of Orthopedic Surgery, Xiangya Hospital, Central South University – sequence: 11 givenname: Hong-Bo surname: He fullname: He, Hong-Bo organization: Department of Orthopedic Surgery, Xiangya Hospital, Central South University – sequence: 12 givenname: Tie-Jian surname: Jiang fullname: Jiang, Tie-Jian organization: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University – sequence: 13 givenname: Min-Xiang surname: Lei fullname: Lei, Min-Xiang organization: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University – sequence: 14 givenname: Mei surname: Wan fullname: Wan, Mei organization: Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine – sequence: 15 givenname: Xu surname: Cao fullname: Cao, Xu email: xcao11@jhmi.edu organization: Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine – sequence: 16 givenname: Xiang-Hang surname: Luo fullname: Luo, Xiang-Hang email: xianghangluo@hotmail.com organization: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28685750$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1qFTEUxwep2Fq7ci8DbgQdzdd8ZCNIsfZCVRBdhySTmZtLJhmTTMvdu_B13PsMPoRPYqb3er0taiDkJPmdP_9zkvvZgXVWZdlDCJ5DgJsXVrphCLACAN_JjhAgsIA1wgd78WF2EsIKpIEpbAi5lx2ipmrKugRH2Ze3-kNBaP3z63dIy1yaKUTlc6_6yfCoQs5tr12vrAo65O3kte1z6abRzMGVjsvcpYwdIdb5wLWNac6Asq2LS2U0N_k7F-Uy6bX5-eKsgD--5VxGfanj-kF2t-MmqJPtepx9Onv98fS8uHj_ZnH66qKQBNW4oB1HZdUiwYHspCSKYFoJRBoIeI1UJ9OOirIEoEMJqGhLG8IpwQIQRKnAx9lio9s6vmKj1wP3a-a4ZtcHzveM-6ilUYxQBAFtKAWkTgKiAaVoMVGi7AQqa560nm20Jjvy9RU3ZicIAZvfhu29TcJfbvBxEoNqpbLRc3PDw80bq5esd5cslUPwtcCTrYB3nycVIht0kMoYbpWbAoMU1riqACoT-vgWunKTt6mzDCOEICENbRL1aN_Rzsrvv5EAuAGkdyF41TGpI4_azQa1-UeZT2_l_L8p2x6Gcf5Xyv8x-jf8FwZH7n0 |
CitedBy_id | crossref_primary_10_1016_j_bioactmat_2021_09_015 crossref_primary_10_15252_embj_2022111762 crossref_primary_10_1007_s11033_023_08709_6 crossref_primary_10_1055_s_0043_1778039 crossref_primary_10_1038_s41419_022_04902_w crossref_primary_10_1186_s12891_025_08476_4 crossref_primary_10_1111_jcmm_16562 crossref_primary_10_3389_fphar_2020_503524 crossref_primary_10_1002_adhm_202102818 crossref_primary_10_1016_j_stemcr_2020_06_007 crossref_primary_10_1002_advs_202309133 crossref_primary_10_1016_j_vph_2022_106998 crossref_primary_10_1021_acsnano_2c03781 crossref_primary_10_1038_s41413_022_00229_6 crossref_primary_10_1038_s42003_023_04567_x crossref_primary_10_3389_fimmu_2023_1124894 crossref_primary_10_1042_BCJ20200157 crossref_primary_10_1080_09513590_2020_1764929 crossref_primary_10_1002_advs_202406398 crossref_primary_10_1097_MD_0000000000031859 crossref_primary_10_1096_fj_201902463RR crossref_primary_10_1016_j_job_2022_05_003 crossref_primary_10_1016_j_actbio_2021_03_011 crossref_primary_10_1002_adhm_202300019 crossref_primary_10_1111_cpr_13178 crossref_primary_10_1111_cpr_13332 crossref_primary_10_1590_1414_431x2024e13339 crossref_primary_10_1016_j_bone_2022_116648 crossref_primary_10_1111_cpr_13054 crossref_primary_10_1016_j_bone_2020_115712 crossref_primary_10_1038_s41413_021_00142_4 crossref_primary_10_1186_s13018_020_02043_4 crossref_primary_10_1590_1414_431x20187816 crossref_primary_10_1016_j_bone_2023_116883 crossref_primary_10_1155_2019_1907906 crossref_primary_10_1111_nyas_14348 crossref_primary_10_1111_cpr_12874 crossref_primary_10_3389_fcell_2020_00744 crossref_primary_10_1016_j_bbrc_2022_02_085 crossref_primary_10_1016_j_cej_2024_151485 crossref_primary_10_3892_mmr_2021_12350 crossref_primary_10_1186_s40659_024_00497_y crossref_primary_10_1007_s42000_024_00599_y crossref_primary_10_1186_s12951_023_02115_7 crossref_primary_10_1038_s41419_022_05348_w crossref_primary_10_1016_j_bioactmat_2020_11_019 crossref_primary_10_1371_journal_pone_0209300 crossref_primary_10_1038_s41413_019_0056_9 crossref_primary_10_1002_adhm_202403837 crossref_primary_10_1097_MD_0000000000032402 crossref_primary_10_1016_j_matdes_2023_112336 crossref_primary_10_3390_ijms231911201 crossref_primary_10_1155_2020_8412468 crossref_primary_10_1016_j_bone_2020_115617 crossref_primary_10_3389_fimmu_2023_1272133 crossref_primary_10_1155_2019_6782653 crossref_primary_10_1242_jcs_216135 crossref_primary_10_1002_jcp_31291 crossref_primary_10_1111_febs_15493 crossref_primary_10_1111_odi_13321 crossref_primary_10_3389_fcell_2020_598263 crossref_primary_10_1038_s41413_023_00259_8 crossref_primary_10_3389_fcvm_2022_841101 crossref_primary_10_3389_fcell_2020_00872 crossref_primary_10_1186_s13018_021_02804_9 crossref_primary_10_1177_09636897221144949 crossref_primary_10_1007_s00774_021_01249_8 crossref_primary_10_1016_j_bone_2021_116223 crossref_primary_10_3390_pharmaceutics14051012 crossref_primary_10_1186_s12967_024_05608_7 crossref_primary_10_3389_fcell_2020_585644 crossref_primary_10_1016_j_ijbiomac_2022_02_148 crossref_primary_10_1021_acsami_2c20715 crossref_primary_10_1038_s41467_021_26455_w crossref_primary_10_14336_AD_2019_0724 crossref_primary_10_1016_j_bioadv_2023_213307 crossref_primary_10_1111_cpr_12693 crossref_primary_10_3389_fendo_2023_1219433 crossref_primary_10_1016_j_gendis_2020_07_013 crossref_primary_10_1111_acel_13077 crossref_primary_10_3390_diseases12100252 crossref_primary_10_1007_s00018_024_05371_4 crossref_primary_10_3390_cells11223552 crossref_primary_10_1038_s41413_021_00138_0 crossref_primary_10_2147_JIR_S345517 crossref_primary_10_1016_j_carbpol_2022_119469 crossref_primary_10_1007_s00592_024_02415_w crossref_primary_10_1111_cpr_12967 crossref_primary_10_1111_cpr_12688 crossref_primary_10_1186_s12951_023_01933_z crossref_primary_10_1016_j_yjmcc_2020_03_015 crossref_primary_10_1186_s13287_021_02150_x crossref_primary_10_32604_biocell_2021_014453 crossref_primary_10_3389_fbioe_2023_1291969 crossref_primary_10_1155_2020_6575127 crossref_primary_10_1126_sciadv_adq6700 crossref_primary_10_1016_j_bbrc_2019_05_113 crossref_primary_10_1016_j_cej_2022_137738 crossref_primary_10_1016_j_omtn_2021_03_016 crossref_primary_10_1016_j_cmet_2020_01_002 crossref_primary_10_3389_fcell_2020_596783 crossref_primary_10_1155_2019_1730978 crossref_primary_10_1186_s12885_024_12541_x crossref_primary_10_1111_cpr_13403 crossref_primary_10_1007_s11657_019_0677_z crossref_primary_10_1186_s12929_021_00732_8 crossref_primary_10_1016_j_beem_2021_101612 crossref_primary_10_1038_s41392_022_00886_3 crossref_primary_10_3390_antiox10081248 crossref_primary_10_18632_aging_101444 crossref_primary_10_3389_fcell_2020_599826 crossref_primary_10_1016_j_omtn_2019_07_023 crossref_primary_10_1038_s41419_020_2377_4 crossref_primary_10_1097_SAP_0000000000002835 crossref_primary_10_3389_fcell_2020_00265 crossref_primary_10_1084_jem_20181554 crossref_primary_10_1007_s10616_020_00389_5 crossref_primary_10_1002_adma_202413238 crossref_primary_10_2174_1573409919666230605123129 crossref_primary_10_1007_s12011_022_03364_7 crossref_primary_10_1111_jcmm_15826 crossref_primary_10_1016_j_cca_2020_08_017 crossref_primary_10_1038_s42003_025_07524_y crossref_primary_10_1111_cpr_12784 crossref_primary_10_1038_s41467_023_44312_w crossref_primary_10_18632_aging_103213 crossref_primary_10_3389_fgene_2020_582366 crossref_primary_10_3892_ijmm_2022_5197 crossref_primary_10_1111_jcmm_18123 crossref_primary_10_4239_wjd_v15_i4_769 crossref_primary_10_1016_j_isci_2021_103604 crossref_primary_10_7717_peerj_12253 crossref_primary_10_1155_2019_1580982 crossref_primary_10_3389_fendo_2024_1394785 crossref_primary_10_1080_15592294_2023_2222246 crossref_primary_10_1002_cbin_11133 crossref_primary_10_1007_s00223_019_00571_8 crossref_primary_10_1002_jcp_29733 crossref_primary_10_3390_ijms21144923 crossref_primary_10_1007_s43032_021_00690_4 crossref_primary_10_1016_j_isci_2023_108092 crossref_primary_10_1111_cpr_13596 crossref_primary_10_1172_JCI176660 crossref_primary_10_2217_epi_2019_0277 crossref_primary_10_1093_cvr_cvz239 |
Cites_doi | 10.1038/nn.2644 10.1038/ncomms11455 10.1016/j.colsurfb.2014.12.001 10.1182/blood-2011-12-399659 10.1038/nm.3668 10.1038/nature13145 10.1128/MMBR.67.4.657-685.2003 10.18632/oncotarget.6589 10.1089/scd.2013.0528 10.1038/ncb1904 10.1038/nature13146 10.1172/JCI62385 10.1126/science.1059796 10.1038/nprot.2015.125 10.1016/j.cell.2009.01.035 10.1002/jbmr.1962 10.1038/nature10783 10.1016/j.tibs.2007.02.006 10.1073/pnas.1018493108 10.1038/nm.3791 10.1074/jbc.M704988200 10.1038/nrd3141 10.18632/oncotarget.8269 10.1055/s-2007-963409 10.1080/15476286.2014.996462 10.1038/nrm2632 10.1016/j.tibtech.2010.07.005 10.18632/oncotarget.5012 10.1172/JCI77716 10.1002/jbmr.2412 10.1172/JCI39832 10.1002/hep.26373 10.1158/1078-0432.CCR-15-0217 10.1111/nyas.12750 10.1016/j.devcel.2007.01.013 10.1002/jbmr.169 10.1038/nrc2791 |
ContentType | Journal Article |
Copyright | The Author(s) 2017 Copyright Nature Publishing Group 2017 Copyright © 2017, The Author(s) 2017 The Author(s) |
Copyright_xml | – notice: The Author(s) 2017 – notice: Copyright Nature Publishing Group 2017 – notice: Copyright © 2017, The Author(s) 2017 The Author(s) |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 SOI 7X8 5PM ADTOC UNPAY DOA |
DOI | 10.1038/ncomms16003 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 6 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-1723 |
EndPage | 11 |
ExternalDocumentID | oai_doaj_org_article_49210989904743bb805bd34eb5fb257a 10.1038/ncomms16003 PMC5504303 28685750 10_1038_ncomms16003 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0R~ 39C 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ AASML ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BAPOH BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LK8 M1P M48 M7P M~E NAO O9- OK1 P2P P62 PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AAYXX CITATION PJZUB PPXIY PQGLB PUEGO CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AZQEC C1K DWQXO EJD FR3 GNUQQ H94 K9. P64 PKEHL PQEST PQUKI PRINS RC3 SOI 7X8 5PM 4.4 ABAWZ ADTOC CAG COF LGEZI LOTEE NADUK NXXTH UNPAY |
ID | FETCH-LOGICAL-c4273-9fa256d2ba0cfcc4e4396b24810a72efc96b9b5500f2cfc69d984a943b04299b3 |
IEDL.DBID | M48 |
ISSN | 2041-1723 |
IngestDate | Wed Aug 27 01:28:06 EDT 2025 Wed Aug 20 00:12:35 EDT 2025 Tue Sep 30 16:46:44 EDT 2025 Thu Sep 04 23:07:32 EDT 2025 Sat Aug 23 14:56:11 EDT 2025 Mon Jul 21 05:56:44 EDT 2025 Wed Oct 01 05:54:20 EDT 2025 Thu Apr 24 22:58:30 EDT 2025 Tue Jun 24 01:11:00 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0 cc-by |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4273-9fa256d2ba0cfcc4e4396b24810a72efc96b9b5500f2cfc69d984a943b04299b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors contributed equally to this work. |
OpenAccessLink | https://www.proquest.com/docview/3222144898?pq-origsite=%requestingapplication% |
PMID | 28685750 |
PQID | 3222144898 |
PQPubID | 546298 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_49210989904743bb805bd34eb5fb257a unpaywall_primary_10_1038_ncomms16003 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5504303 proquest_miscellaneous_1917366025 proquest_journals_3222144898 pubmed_primary_28685750 crossref_citationtrail_10_1038_ncomms16003 crossref_primary_10_1038_ncomms16003 springer_journals_10_1038_ncomms16003 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20170707 |
PublicationDateYYYYMMDD | 2017-07-07 |
PublicationDate_xml | – month: 7 year: 2017 text: 20170707 day: 7 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Nature communications |
PublicationTitleAbbrev | Nat Commun |
PublicationTitleAlternate | Nat Commun |
PublicationYear | 2017 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | C Liang (BFncomms16003_CR28) 2015; 21 C Li (BFncomms16003_CR32) 2013; 28 P Jaakkola (BFncomms16003_CR14) 2001; 292 AD Keefe (BFncomms16003_CR30) 2010; 9 R Schäfer (BFncomms16003_CR19) 2007; 179 SK Ramasamy (BFncomms16003_CR6) 2014; 507 Y Zhang (BFncomms16003_CR11) 2011; 108 JD Hoeck (BFncomms16003_CR13) 2010; 13 C Li (BFncomms16003_CR33) 2016; 7 C-J Li (BFncomms16003_CR10) 2015; 125 L Cerchia (BFncomms16003_CR29) 2010; 28 Y Zhao (BFncomms16003_CR9) 2007; 32 C Chao (BFncomms16003_CR24) 2015; 21 DT Jones (BFncomms16003_CR27) 2006; 5 AP Kusumbe (BFncomms16003_CR5) 2014; 507 CM Phillips (BFncomms16003_CR18) 2009; 11 P Ray (BFncomms16003_CR17) 2012; 122 CM Phillips (BFncomms16003_CR37) 2009; 11 H Li (BFncomms16003_CR39) 2009; 119 N Agrawal (BFncomms16003_CR16) 2003; 67 P Tang (BFncomms16003_CR12) 2014; 11 RW Carthew (BFncomms16003_CR7) 2009; 136 H Xie (BFncomms16003_CR40) 2011; 26 H Xie (BFncomms16003_CR20) 2014; 20 VN Kim (BFncomms16003_CR8) 2009; 10 P Qi (BFncomms16003_CR38) 2015; 126 L Ding (BFncomms16003_CR3) 2012; 481 JJ Yan (BFncomms16003_CR21) 2015; 6 P Ray (BFncomms16003_CR36) 2012; 122 R Wang (BFncomms16003_CR23) 2013; 58 P Koivunen (BFncomms16003_CR15) 2007; 282 MI Almeida (BFncomms16003_CR25) 2015; 7 K Red-Horse (BFncomms16003_CR2) 2007; 12 A Liu (BFncomms16003_CR22) 2016; 7 W Wang (BFncomms16003_CR31) 2014; 23 Y Tashiro (BFncomms16003_CR1) 2012; 119 JM Butler (BFncomms16003_CR4) 2010; 10 J Grünhagen (BFncomms16003_CR26) 2015; 30 AP Kusumbe (BFncomms16003_CR34) 2015; 10 C Li (BFncomms16003_CR35) 2015; 1364 40550801 - Nat Commun. 2025 Jun 23;16(1):5365. doi: 10.1038/s41467-025-60624-5. |
References_xml | – volume: 13 start-page: 1365 year: 2010 ident: BFncomms16003_CR13 publication-title: Nat. Neurosci. doi: 10.1038/nn.2644 – volume: 7 start-page: 11455 year: 2016 ident: BFncomms16003_CR33 publication-title: Nat. Commun. doi: 10.1038/ncomms11455 – volume: 126 start-page: 70 year: 2015 ident: BFncomms16003_CR38 publication-title: Colloids Surf. B Biointerfaces doi: 10.1016/j.colsurfb.2014.12.001 – volume: 119 start-page: 6382 year: 2012 ident: BFncomms16003_CR1 publication-title: Blood doi: 10.1182/blood-2011-12-399659 – volume: 20 start-page: 1270 year: 2014 ident: BFncomms16003_CR20 publication-title: Nat. Med. doi: 10.1038/nm.3668 – volume: 507 start-page: 323 year: 2014 ident: BFncomms16003_CR5 publication-title: Nature doi: 10.1038/nature13145 – volume: 67 start-page: 657 year: 2003 ident: BFncomms16003_CR16 publication-title: Microbiol. Mol. Biol. Rev. doi: 10.1128/MMBR.67.4.657-685.2003 – volume: 7 start-page: 7 year: 2015 ident: BFncomms16003_CR25 publication-title: Oncotarget doi: 10.18632/oncotarget.6589 – volume: 23 start-page: 1392 year: 2014 ident: BFncomms16003_CR31 publication-title: Stem Cells Dev. doi: 10.1089/scd.2013.0528 – volume: 11 start-page: 934 year: 2009 ident: BFncomms16003_CR18 publication-title: Nat. Cell Biol. doi: 10.1038/ncb1904 – volume: 507 start-page: 376 year: 2014 ident: BFncomms16003_CR6 publication-title: Nature doi: 10.1038/nature13146 – volume: 122 start-page: 1734 year: 2012 ident: BFncomms16003_CR36 publication-title: J. Clin. Invest. doi: 10.1172/JCI62385 – volume: 292 start-page: 468 year: 2001 ident: BFncomms16003_CR14 publication-title: Science doi: 10.1126/science.1059796 – volume: 10 start-page: 1904 year: 2015 ident: BFncomms16003_CR34 publication-title: Nat. Protoc. doi: 10.1038/nprot.2015.125 – volume: 5 start-page: 2193 year: 2006 ident: BFncomms16003_CR27 publication-title: Am. Assoc. Cancer Res. – volume: 136 start-page: 642 year: 2009 ident: BFncomms16003_CR7 publication-title: Cell doi: 10.1016/j.cell.2009.01.035 – volume: 11 start-page: 934 year: 2009 ident: BFncomms16003_CR37 publication-title: Nat. Cell Biol. doi: 10.1038/ncb1904 – volume: 28 start-page: 2094 year: 2013 ident: BFncomms16003_CR32 publication-title: J. Bone Miner. Res. doi: 10.1002/jbmr.1962 – volume: 481 start-page: 457 year: 2012 ident: BFncomms16003_CR3 publication-title: Nature doi: 10.1038/nature10783 – volume: 32 start-page: 189 year: 2007 ident: BFncomms16003_CR9 publication-title: Trends Biochem. Sci. doi: 10.1016/j.tibs.2007.02.006 – volume: 108 start-page: 9863 year: 2011 ident: BFncomms16003_CR11 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1018493108 – volume: 21 start-page: 288 year: 2015 ident: BFncomms16003_CR28 publication-title: Nat. Med. doi: 10.1038/nm.3791 – volume: 282 start-page: 30544 year: 2007 ident: BFncomms16003_CR15 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M704988200 – volume: 9 start-page: 537 year: 2010 ident: BFncomms16003_CR30 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd3141 – volume: 7 start-page: 25801 year: 2016 ident: BFncomms16003_CR22 publication-title: Oncotarget doi: 10.18632/oncotarget.8269 – volume: 179 start-page: 1009 year: 2007 ident: BFncomms16003_CR19 publication-title: Rofo doi: 10.1055/s-2007-963409 – volume: 11 start-page: 1355 year: 2014 ident: BFncomms16003_CR12 publication-title: RNA Biol. doi: 10.1080/15476286.2014.996462 – volume: 122 start-page: 1734 year: 2012 ident: BFncomms16003_CR17 publication-title: J. Clin. Invest. doi: 10.1172/JCI62385 – volume: 10 start-page: 126 year: 2009 ident: BFncomms16003_CR8 publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm2632 – volume: 28 start-page: 517 year: 2010 ident: BFncomms16003_CR29 publication-title: Trends Biotechnol. doi: 10.1016/j.tibtech.2010.07.005 – volume: 6 start-page: 29527 year: 2015 ident: BFncomms16003_CR21 publication-title: Oncotarget doi: 10.18632/oncotarget.5012 – volume: 125 start-page: 1509 year: 2015 ident: BFncomms16003_CR10 publication-title: J. Clin. Invest. doi: 10.1172/JCI77716 – volume: 30 start-page: 796 year: 2015 ident: BFncomms16003_CR26 publication-title: J. Bone Miner. Res. doi: 10.1002/jbmr.2412 – volume: 119 start-page: 3666 year: 2009 ident: BFncomms16003_CR39 publication-title: J. Clin. Invest. doi: 10.1172/JCI39832 – volume: 58 start-page: 642 year: 2013 ident: BFncomms16003_CR23 publication-title: Hepatology doi: 10.1002/hep.26373 – volume: 21 start-page: 4922 year: 2015 ident: BFncomms16003_CR24 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-15-0217 – volume: 1364 start-page: 62 year: 2015 ident: BFncomms16003_CR35 publication-title: Ann. N. Y. Acad. Sci. doi: 10.1111/nyas.12750 – volume: 12 start-page: 181 year: 2007 ident: BFncomms16003_CR2 publication-title: Dev. Cell doi: 10.1016/j.devcel.2007.01.013 – volume: 26 start-page: 156 year: 2011 ident: BFncomms16003_CR40 publication-title: J. Bone Miner. Res. doi: 10.1002/jbmr.169 – volume: 10 start-page: 138 year: 2010 ident: BFncomms16003_CR4 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2791 – reference: 40550801 - Nat Commun. 2025 Jun 23;16(1):5365. doi: 10.1038/s41467-025-60624-5. |
SSID | ssj0000391844 |
Score | 2.6073797 |
Snippet | A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31
hi
Emcn
hi
), is identified as coupling angiogenesis and osteogenesis. The... A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31 hi Emcn hi ), is identified as coupling angiogenesis and osteogenesis. The... A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31 Emcn ), is identified as coupling angiogenesis and osteogenesis. The abundance... A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31hiEmcnhi), is identified as coupling angiogenesis and osteogenesis. The abundance... Abstract A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31hiEmcnhi), is identified as coupling angiogenesis and osteogenesis. The... |
SourceID | doaj unpaywall pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 16003 |
SubjectTerms | 13/109 13/31 14/19 38 38/61 692/4019/592/16 Aging Angiogenesis Animals Antagomirs - genetics Antagomirs - metabolism Aptamers Aptamers, Nucleotide - genetics Aptamers, Nucleotide - metabolism Bone and Bones - blood supply Bone and Bones - metabolism Bone and Bones - pathology Bone Density Bone growth Bone loss Bone mass Cdc4 protein Clusters Coupling Endothelial cells Endothelium F-Box-WD Repeat-Containing Protein 7 - genetics F-Box-WD Repeat-Containing Protein 7 - metabolism Gene Expression Regulation, Developmental Humanities and Social Sciences Humans Hypoxia-Inducible Factor 1, alpha Subunit - genetics Hypoxia-Inducible Factor 1, alpha Subunit - metabolism Hypoxia-inducible factor 1a Mice Mice, Knockout MicroRNAs - agonists MicroRNAs - antagonists & inhibitors MicroRNAs - genetics MicroRNAs - metabolism Molecular Targeted Therapy multidisciplinary Neovascularization, Physiologic - genetics Osteogenesis Osteogenesis - genetics Osteoporosis Osteoporosis - genetics Osteoporosis - metabolism Osteoporosis - pathology Osteoporosis - therapy Platelet Endothelial Cell Adhesion Molecule-1 - agonists Platelet Endothelial Cell Adhesion Molecule-1 - genetics Platelet Endothelial Cell Adhesion Molecule-1 - metabolism Procollagen-proline dioxygenase Prolyl Hydroxylases - genetics Prolyl Hydroxylases - metabolism Receptor, Notch1 - genetics Receptor, Notch1 - metabolism Science Science (multidisciplinary) Sialoglycoproteins - agonists Sialoglycoproteins - genetics Sialoglycoproteins - metabolism Signal Transduction Therapeutic targets Transmembrane domains |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQJQQcEP-kFGSk9oIUNXHsJD4CYrUgtQdEpd4i23GWSKlTNRuhvXPo63DnGXgInoQZJxt2xQouHHczWnk9nz3f2Jn5CDmsKgu7ntKhkJyHXGQ2lCaTYalyFiuGArd4oH9yms7P-Idzcb4h9YXvhA3tgYeJO-YSkhIJWUHEIdhpnUdClwm3WlQa4OapEYSxjWTK78GJhNSFjwV5UZIfO3DgRRdDfE-2QpDv1L-LXv75luR0VXqH3OrdpVp9UU2zEY1m98jdkUbS18Pw75Mb1j0gNwdhydVD8vWk_oiqbj-vv8dSUNP02A-BXg3C87ajyi3qdoH7XN3RoVSRmrbH8twFxbNZisUfk4Ve0QtVu-UgJ0GtK7FwqwHs0tMW_A6_V9L5-1kY__hGsVQCFSkekbPZu09v5-GotxAaDiwmlJUCAlQyrSJTGcMtkJVUM57HkcqYrQx8khpSmqhiYJDKUuZcSfCKj2o6eUz2XOvsU0Kz0khRpUgeGc90ooUyyJSAz-jSKB2QV2sXFGZsRo6aGE3hL8WTvNjwV0AOJ-PLoQfHbrM36MvJBBtn-y8ATsUIp-JfcArIwRoJxbiauwJvoyDxzGUekJfTY1iHeLminG37rsC8N0lToJABeTIAZxoJy1MUQo0Ckm1Bamuo209c_dn3-hbYYQ7_29EafL-HtXMOjiZk_m2u9v_HXD0jtxmSHH_YfUD2lle9fQ4Ubalf-NX4Cw2JPSQ priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELagCAEHxH8DBRmpvSBFTRwnsU8IEMuC1B4QlXqLbMfZRkqdZbNRtXcOvA53noGH4EmYSbJpV6x6TDKKHM94_HkmMx8h-0Vhwesp7ceSc5_HqfWlSaWfK8FCxZDgFgP6R8fJ9IR_OY1Ph4BbM_xWufaJnaPOa4Mx8kPMCAD4F1K8nX_3kTUKs6sDhcZNcitkYElYKT75NMZYsPu54HwoywsicejgledNCLt8tLERdf36t4HM__-VHBOm98id1s3V6kJV1ZU9afKA3B_AJH3Xa_8huWHdI3K7p5dcPSY_jsqvyO329-fvUMbUVC12RaCLnn7eNlS5WVnP0NuVDe0LFqmpWyzSnVGM0FIsARkl9Iqeq9Ite1IJal2O5VsVWDA9rkH78L6cTj9P_PDPL4oFE8hL8YScTD5--zD1B9YF33DAMr4sFMCgnGkVmMIYbgGyJJpxEQYqZbYwcCU1HGyCgoFAInMpuJI80t3epqOnZMfVzu4SmuZGxkWCEJLxVEc6VgbxEqAanRulPfJmrYLMDC3JkRmjyrrUeCSyK_ryyP4oPO87cWwXe4-6HEWwfXZ3o17MsmE1ZlzCSVfCUTPggKC0FkGs84hbHRcafJjyyN7aErJhTTfZpQV65PX4GFYjpliUs3XbZHj6jZIEgKRHnvWGM46EiQTpUAOPpBsmtTHUzSeuPOs6fsfYZw6_7WBtfJfD2joHB6NlXjdXz6__zBfkLkMQ0wWz98jOctHalwDBlvpVt87-AZl1NaM priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwELZQEQIOFf-kFGSk9oIUkR87sY-wYrUgtQdEpd4i23GWSKlTbTZCe--hr8OdZ-Ah-iSdSbJhV6wQxySTyLHH9je25_sIOSoKC6Oe0j6XjPmMp9aXJpV-rkQUqggFbnFB_-Q0mZ2xL-f8fODZboZjlT2lZTdMr0-HvXdwddGEScfseVekcYjn9ybJZFxQQapzwdiQgxfEYvOdrVmnI-ffhSj_Phg57o4-JPdbd6lWP1RVbUxA00dkf0CO9ENf1sfkjnVPyL1eS3L1lFydlF9RyO3m-lcoOTVVixQIdNFrzduGKjcv6zkObWVD--xEauoWM3LnFJdjKeZ7jBZ6RS9U6Za9ggS1LsdcrQrclZ7W0NTwvZzOPk_98PdPitkRKELxjJxNP32bzPxBYsE3DICLLwsFmCePtApMYQyzgE8SHTERBiqNbGHgSmqIYoIiAoNE5lIwJVmsu4lMx8_JnqudfUlomhvJiwTxYsRSHWuuDIIjgDA6N0p75N26CTIz8I-jDEaVdfvgscg22ssjR6PxZU-7sdvsI7blaIJc2d2NejHPBt_JmISwVkJcGTCAS1qLgOs8ZlbzQsOApTxyuPaEbOjATYYbUBBrCik88nZ8DF0P91OUs3XbZBjqxkkCqNEjL3rHGUsSiQS1TwOPpFsutVXU7Seu_N7Re3MklcN_O147359i7ayD49Ez_1VXB__5vVfkQYTQpVvCPiR7y0VrXwPwWuo3XYe7Bfl-Mjg priority: 102 providerName: Springer Nature – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB6VVAg48H4YClqk9oLk1o_1Y48FEQWkRhUiUjlZu-t1sEjtKomFwpkDf4c7v4EfwS9hxi8SiBAcHY-j9Xp25pudnfkA9rPMoNWTyg4E5zYPImMLHQk7lbHnSo8IbmlD_2Qcjib89VlwtgNHXS1MfWi_bmlZm-nudNhRgVfnCxfdM8Z-aXYJdkPKKA1gdzI-PX5HFHIOd210x35bhef48fpTG36nbs-_DVP-eTSyz49egytVcSFXH-VstuaChjfgtBt8c_Lkw2G1VIf60299Hf_j7W7C9RaOsuNG5BbsmOI2XG4IKld34PNJ_obY4X58-eaKgOlZRX0V2LwhsDcLJotpXk7JXuYL1pQ8Ml1WVOY7ZbTHy6iIpJdQK3Yu82LZ0FIwU6RUADbDNcDGJeoP_l_KRq-Gtvv9K6OSC2K2uAuT4cu3L0Z2y9tga45oyBaZRCCVeko6OtOaGwQ9ofJ47Doy8kym8UooDI2czEOBUKQi5lJwX9XeUfn3YFCUhXkALEq1CLKQQKjHI-WrQGpCXIiLVKqlsuBZ91UT3TY1J26NWVIn1_04WZtaC_Z74Yuml8d2seekHr0INeCufyjn06T9ZAkXGCsLDFYdjhhMqdgJVOpzo4JMoRWUFux1ypW0VmGRUFYLA9hYxBY87W_jeqYkjSxMWS0Sip991G0vsOB-o4v9SLw4JEJVx4JoQ0s3hrp5p8jf1z3DA-pUR-920Onzr2FtnYODXtn_NlcP_1HuEVz1CA_V--J7MFjOK_MY0dxSPWlX8E8AzFFZ priority: 102 providerName: Unpaywall |
Title | MiR-497∼195 cluster regulates angiogenesis during coupling with osteogenesis by maintaining endothelial Notch and HIF-1α activity |
URI | https://link.springer.com/article/10.1038/ncomms16003 https://www.ncbi.nlm.nih.gov/pubmed/28685750 https://www.proquest.com/docview/3222144898 https://www.proquest.com/docview/1917366025 https://pubmed.ncbi.nlm.nih.gov/PMC5504303 https://www.nature.com/articles/ncomms16003.pdf https://doaj.org/article/49210989904743bb805bd34eb5fb257a |
UnpaywallVersion | publishedVersion |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: KQ8 dateStart: 20150101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: Inspec with Full Text customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: ADMLS dateStart: 20121101 isFulltext: true titleUrlDefault: https://www.ebsco.com/products/research-databases/inspec-full-text providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: DIK dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: RPM dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVAQT databaseName: Springer Nature - nature.com Journals - Fully Open Access customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: NAO dateStart: 20101201 isFulltext: true titleUrlDefault: https://www.nature.com/siteindex/index.html providerName: Nature Publishing – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2041-1723 dateEnd: 20171231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: 7X7 dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2041-1723 dateEnd: 20171231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: BENPR dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Technology Collection customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: 8FG dateStart: 20100401 isFulltext: true titleUrlDefault: https://search.proquest.com/technologycollection1 providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2041-1723 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: M48 dateStart: 20101001 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: AAJSJ dateStart: 20101201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: C6C dateStart: 20101201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELb2IQQcEG8CS2WkXQ5IWRLHefiAULfaUiq1Wi1UKqfIdpISKZt0-xD0zoG_w53fwI_glzCTpGELFeKSKvEocuyx5xtPZz5CDpMkhl1PKtMVnJvc9WNTaF-YkQyYLRkS3OKB_mDo9Ua8P3bHO2SdQlAP4Hyra4d8UqNZdvz5cvUaFvyrKmU8eJnD3FzMbTDdzvPppYmMUhh5rek1dsk-WCmGGj-ooX-5SzsCnBsMOjOL2ybYcadO3_vjlRsGq6zrvw2M_v2fyiawepNcX-ZTufoks-yK7ereJrdq0EnblZbcITtxfpdcq2goV_fIl0F6jhxwP79-t4VLdbbE6gl0VtHUx3Mq80laTHBXTOe0SmykulhiMu-E4kkuxVSRRkKt6IVM80VFPkHjPMI0rww0nQ4L0BJ4X0R7b7um_eMbxcQK5K-4T0bd0_ednlmzM5iaA-YxRSIBLkVMSUsnWvMYoI2nGA9sS_osTjTcCQUOkJUwEPBEJAIuBXdUaQOV84Ds5UUePyLUj7RwEw-hJuO-cpQrNeIqQD8q0lIZ5MV6CkJdly5HBo0sLEPoThBemS-DHDbC06pix3axE5zLRgTLbJcPitkkrFdtyAV4xAJcUosD0lIqsFwVOTxWbqJgr5MGOVhrQrhW3RBjV-CmBiIwyLOmGVYthmJkHhfLeYhesuN5ADgN8rBSnKYnLPCQNtUyiL-hUhtd3WzJ049lZXAX69Hhtx2tle93t7aOwVGjmf8aq8f_8R1PyA2GiKc8-T4ge4vZMn4KeG2hWmTXH_twDbpvWmS_3e6_68Pvyenw7ByedrxOqzwJaZULFFpGw7P2h1_cw0xd |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIlQ4IN4YCixSc0Gy6tjrxx4Q4hUltMkBtVJvZne9DpFSO8SJqtw58GuQuPMb-BH8Emb8aiOi3nq0PbJ2vfP4dtYzH8Bemhr0elLZvuDc5n5obKFDYScycrvSJYJbSugPR0H_mH868U-24GdTC0O_VTY-sXTUSa4pR75PJwII_iMRvZl9s4k1ik5XGwqNSi0OzOoMt2zF68EHXN-O6_Y-Hr3v2zWrgK05xmpbpBLDfOIq6ehUa24wJAfK5VHXkaFrUo1XQiFwd1IXBQKRiIhLwT1V-m7l4XuvwXXuOZx69YcnYZvToW7rEed1GaDjRfsZTuG06CKq8NYCX8kPsAnU_v9vZntAewt2ltlMrs7kdHohBvbuwO0avLK3lbbdhS2T3YMbFZ3l6j58H04-E5fc3x-_u8JnerqkLgxsXtHdm4LJbDzJx-RdJwWrCiSZzpdUFDxmlBFmVHLSSqgVO5WTbFGRWDCTJVQuNkWLYaMctQ3fl7D-oGd3__xiVKBBPBgP4PhK1uMhbGd5Zh4DCxMt_DQgyOryUHnKl5rwGaIolWipLHjVLEGs6xboxMQxjcujeC-KL6yXBXut8Kzq_LFZ7B2tZStC7brLG_l8HNfWH3OBO2uBW1uHI2JTKnJ8lXjcKD9V6DOlBbuNJsS1Dynic4234GX7GK2fjnRkZvJlEdNu2wsCBK4WPKoUpx2JGwVEv-pYEK6p1NpQ159kk69lh3Gf-trR3DqN8p0Pa-M36LSaedm3enL5NF_ATv9oeBgfDkYHT-GmSwCqTKTvwvZivjTPEP4t1PPS5hh8uWoj_wcQdXI3 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIl4HxBtDgUVqLkhWHHv92ANCQIlSSiOEqJSb2V2vQ6TUDnGiKncO_B2uiN_Aj-CXMONXGxH11mPikbXrmZ39dmZnPoDdNDXo9aSyfcG5zf3Q2EKHwk5k5PakSwS3FNA_HAaDI_5-5I-24FdTC0PXKhufWDrqJNcUI-9SRgDBfySiblpfi_i41381-2YTgxRlWhs6jcpEDszqBI9vxcv9PdR1x3X77z6_Hdg1w4CtOe7btkglbvmJq6SjU625we05UC6Peo4MXZNq_CUUgngndVEgEImIuBTcU6UfVx6-9xJcDj3u0XWycBS28R3qvB5xXpcEOl7UzXA6x0UPEYa3tgmWXAGbAO7_9zTbZO0NuLbMZnJ1IqfTM_th_xbcrIEse11Z3m3YMtkduFJRW67uwvfDySfilfv743dP-ExPl9SRgc3NmPjCTMFkNp7kY_K0k4JVxZJM50sqEB4zig4zKj9pJdSKHctJtqgILZjJEiodm-LqYcMcLQ_fl7DBft_u_fnJqFiDODHuwdGF6OM-bGd5Zh4CCxMt_DQg-OryUHnKl5qwGiIqlWipLHjRqCDWdTt0YuWYxmVa3oviM_qyYLcVnlVdQDaLvSFdtiLUurv8I5-P49oTxFzgKVvgMdfhiN6UihxfJR43yk8V-k9pwU5jCXHtT4r41PoteN4-Rk9A6R2ZmXxZxHTy9oIAQawFDyrDaUfiRgFRsToWhGsmtTbU9SfZ5GvZbdynHnc0t05jfKfD2vgNOq1lnvetHp0_zWdwFZd3_GF_ePAYrruEpcqY-g5sL-ZL8wSR4EI9LZccgy8Xvcb_ASn2dnI |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB6VVAg48H4YClqk9oLk1o_1Y48FEQWkRhUiUjlZu-t1sEjtKomFwpkDf4c7v4EfwS9hxi8SiBAcHY-j9Xp25pudnfkA9rPMoNWTyg4E5zYPImMLHQk7lbHnSo8IbmlD_2Qcjib89VlwtgNHXS1MfWi_bmlZm-nudNhRgVfnCxfdM8Z-aXYJdkPKKA1gdzI-PX5HFHIOd210x35bhef48fpTG36nbs-_DVP-eTSyz49egytVcSFXH-VstuaChjfgtBt8c_Lkw2G1VIf60299Hf_j7W7C9RaOsuNG5BbsmOI2XG4IKld34PNJ_obY4X58-eaKgOlZRX0V2LwhsDcLJotpXk7JXuYL1pQ8Ml1WVOY7ZbTHy6iIpJdQK3Yu82LZ0FIwU6RUADbDNcDGJeoP_l_KRq-Gtvv9K6OSC2K2uAuT4cu3L0Z2y9tga45oyBaZRCCVeko6OtOaGwQ9ofJ47Doy8kym8UooDI2czEOBUKQi5lJwX9XeUfn3YFCUhXkALEq1CLKQQKjHI-WrQGpCXIiLVKqlsuBZ91UT3TY1J26NWVIn1_04WZtaC_Z74Yuml8d2seekHr0INeCufyjn06T9ZAkXGCsLDFYdjhhMqdgJVOpzo4JMoRWUFux1ypW0VmGRUFYLA9hYxBY87W_jeqYkjSxMWS0Sip991G0vsOB-o4v9SLw4JEJVx4JoQ0s3hrp5p8jf1z3DA-pUR-920Onzr2FtnYODXtn_NlcP_1HuEVz1CA_V--J7MFjOK_MY0dxSPWlX8E8AzFFZ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MiR-497%E2%88%BC195+cluster+regulates+angiogenesis+during+coupling+with+osteogenesis+by+maintaining+endothelial+Notch+and+HIF-1%CE%B1+activity&rft.jtitle=Nature+communications&rft.au=Yang%2C+Mi&rft.au=Li%2C+Chang-Jun&rft.au=Sun%2C+Xi&rft.au=Guo%2C+Qi&rft.date=2017-07-07&rft.issn=2041-1723&rft.eissn=2041-1723&rft.volume=8&rft.spage=16003&rft_id=info:doi/10.1038%2Fncomms16003&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |